Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bruker Corporation (BRKR : NSDQ)
 
 • Company Description   
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.

Number of Employees: 11,396

 
 • Price / Volume Information   
Yesterday's Closing Price: $41.20 Daily Weekly Monthly
20 Day Moving Average: 2,234,206 shares
Shares Outstanding: 151.53 (millions)
Market Capitalization: $6,243.11 (millions)
Beta: 1.18
52 Week High: $72.94
52 Week Low: $34.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 12.17% 7.31%
12 Week 6.46% -13.15%
Year To Date -29.72% -33.38%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
40 Manning Road
-
Billerica,MA 01821
USA
ph: 978-663-3660
fax: 978-663-5585
investor.relations@bruker.com http://www.bruker.com
 
 • General Corporate Information   
Officers
Frank H. Laukien - President; Chief Executive Officer and Chairman
Gerald N. Herman - Executive Vice President and Chief Financial Offic
Thomas Bures - Chief Accounting Officer
Bonnie H. Anderson - Director
Cynthia Friend - Director

Peer Information
Bruker Corporation (DNEX)
Bruker Corporation (T.PUR)
Bruker Corporation (CALP.)
Bruker Corporation (CCSI.)
Bruker Corporation (NEWP.)
Bruker Corporation (PBSC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: INSTRU-SCIENTFC
Sector: Computer and Technology
CUSIP: 116794108
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 151.53
Most Recent Split Date: (:1)
Beta: 1.18
Market Capitalization: $6,243.11 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.49%
Current Fiscal Quarter EPS Consensus Estimate: $0.43 Indicated Annual Dividend: $0.20
Current Fiscal Year EPS Consensus Estimate: $2.45 Payout Ratio: 0.09
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 6.09% Last Dividend Paid: 06/16/2025 - $0.05
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 16.83
Trailing 12 Months: 17.53
PEG Ratio: 2.77
Price Ratios
Price/Book: 3.41
Price/Cash Flow: 11.48
Price / Sales: 1.81
EPS Growth
vs. Year Ago Period: -11.32%
vs. Previous Quarter: -38.16%
Sales Growth
vs. Year Ago Period: 11.04%
vs. Previous Quarter: -18.19%
ROE
06/30/25 - -
03/31/25 - 19.47
12/31/24 - 21.01
ROA
06/30/25 - -
03/31/25 - 5.95
12/31/24 - 6.46
Current Ratio
06/30/25 - -
03/31/25 - 1.57
12/31/24 - 1.60
Quick Ratio
06/30/25 - -
03/31/25 - 0.74
12/31/24 - 0.77
Operating Margin
06/30/25 - -
03/31/25 - 10.26
12/31/24 - 10.71
Net Margin
06/30/25 - -
03/31/25 - 2.31
12/31/24 - 3.36
Pre-Tax Margin
06/30/25 - -
03/31/25 - 4.65
12/31/24 - 6.15
Book Value
06/30/25 - -
03/31/25 - 12.10
12/31/24 - 11.85
Inventory Turnover
06/30/25 - -
03/31/25 - 1.54
12/31/24 - 1.52
Debt-to-Equity
06/30/25 - -
03/31/25 - 1.13
12/31/24 - 1.15
Debt-to-Capital
06/30/25 - -
03/31/25 - 53.33
12/31/24 - 53.65
 

Powered by Zacks Investment Research ©